Ex vivo human placental transfer of human immunodeficiency virus-1 p24 antigen

R. E. Bawdon, M. Gravell, S. Roberts, R. Hamilton, J. Dax, J. Sever

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

OBJECTIVE: Our purpose was to determine whether human immunodeficiency virus-1 p24 antigen crosses the human placenta and, if so, to determine its clearance index relative to antipyrine. STUDY DESIGN: Eight term human placentas from uncomplicated vaginal or cesarean section deliveries were studied by ex vivo placental perfusion to determine the incidence and concentration required to obtain passage of p24 antigen into the fetal circulation. The concentration of p24 antigen was determined by antigen-capture enzyme immunoassay. RESULTS: The passage of p24 antigen into the fetal circulation was observed in three of five placentas studied when the p24 antigen concentration in the maternal circulation was 2942.8 ± 401 pg/ml. When the p24 concentration in the maternal circulation was raised approximately fourfold to 14506 ± 4124 pg/ml, p24 antigen passed to the fetal circulation in two of three placentas and in three of three placentas in the closed perfusion system. CONCLUSIONS: p24 antigen crossed the human placenta to the fetal circulation in what appears to be a concentration-dependent manner.

Original languageEnglish (US)
Pages (from-to)530-532
Number of pages3
JournalAmerican Journal of Obstetrics and Gynecology
Volume172
Issue number2 PART 1
DOIs
StatePublished - 1995

Fingerprint

HIV-1
Placenta
Antigens
Perfusion
Mothers
Antipyrine
Immunoenzyme Techniques
Cesarean Section
Incidence

Keywords

  • ex vivo
  • Human immunodeficiency virus-1 p24 antigen
  • human placenta
  • transfer

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Medicine(all)

Cite this

Ex vivo human placental transfer of human immunodeficiency virus-1 p24 antigen. / Bawdon, R. E.; Gravell, M.; Roberts, S.; Hamilton, R.; Dax, J.; Sever, J.

In: American Journal of Obstetrics and Gynecology, Vol. 172, No. 2 PART 1, 1995, p. 530-532.

Research output: Contribution to journalArticle

Bawdon, R. E. ; Gravell, M. ; Roberts, S. ; Hamilton, R. ; Dax, J. ; Sever, J. / Ex vivo human placental transfer of human immunodeficiency virus-1 p24 antigen. In: American Journal of Obstetrics and Gynecology. 1995 ; Vol. 172, No. 2 PART 1. pp. 530-532.
@article{3f2fcb7f0c0f423b8dd0f8073ce23d0b,
title = "Ex vivo human placental transfer of human immunodeficiency virus-1 p24 antigen",
abstract = "OBJECTIVE: Our purpose was to determine whether human immunodeficiency virus-1 p24 antigen crosses the human placenta and, if so, to determine its clearance index relative to antipyrine. STUDY DESIGN: Eight term human placentas from uncomplicated vaginal or cesarean section deliveries were studied by ex vivo placental perfusion to determine the incidence and concentration required to obtain passage of p24 antigen into the fetal circulation. The concentration of p24 antigen was determined by antigen-capture enzyme immunoassay. RESULTS: The passage of p24 antigen into the fetal circulation was observed in three of five placentas studied when the p24 antigen concentration in the maternal circulation was 2942.8 ± 401 pg/ml. When the p24 concentration in the maternal circulation was raised approximately fourfold to 14506 ± 4124 pg/ml, p24 antigen passed to the fetal circulation in two of three placentas and in three of three placentas in the closed perfusion system. CONCLUSIONS: p24 antigen crossed the human placenta to the fetal circulation in what appears to be a concentration-dependent manner.",
keywords = "ex vivo, Human immunodeficiency virus-1 p24 antigen, human placenta, transfer",
author = "Bawdon, {R. E.} and M. Gravell and S. Roberts and R. Hamilton and J. Dax and J. Sever",
year = "1995",
doi = "10.1016/0002-9378(95)90568-5",
language = "English (US)",
volume = "172",
pages = "530--532",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "2 PART 1",

}

TY - JOUR

T1 - Ex vivo human placental transfer of human immunodeficiency virus-1 p24 antigen

AU - Bawdon, R. E.

AU - Gravell, M.

AU - Roberts, S.

AU - Hamilton, R.

AU - Dax, J.

AU - Sever, J.

PY - 1995

Y1 - 1995

N2 - OBJECTIVE: Our purpose was to determine whether human immunodeficiency virus-1 p24 antigen crosses the human placenta and, if so, to determine its clearance index relative to antipyrine. STUDY DESIGN: Eight term human placentas from uncomplicated vaginal or cesarean section deliveries were studied by ex vivo placental perfusion to determine the incidence and concentration required to obtain passage of p24 antigen into the fetal circulation. The concentration of p24 antigen was determined by antigen-capture enzyme immunoassay. RESULTS: The passage of p24 antigen into the fetal circulation was observed in three of five placentas studied when the p24 antigen concentration in the maternal circulation was 2942.8 ± 401 pg/ml. When the p24 concentration in the maternal circulation was raised approximately fourfold to 14506 ± 4124 pg/ml, p24 antigen passed to the fetal circulation in two of three placentas and in three of three placentas in the closed perfusion system. CONCLUSIONS: p24 antigen crossed the human placenta to the fetal circulation in what appears to be a concentration-dependent manner.

AB - OBJECTIVE: Our purpose was to determine whether human immunodeficiency virus-1 p24 antigen crosses the human placenta and, if so, to determine its clearance index relative to antipyrine. STUDY DESIGN: Eight term human placentas from uncomplicated vaginal or cesarean section deliveries were studied by ex vivo placental perfusion to determine the incidence and concentration required to obtain passage of p24 antigen into the fetal circulation. The concentration of p24 antigen was determined by antigen-capture enzyme immunoassay. RESULTS: The passage of p24 antigen into the fetal circulation was observed in three of five placentas studied when the p24 antigen concentration in the maternal circulation was 2942.8 ± 401 pg/ml. When the p24 concentration in the maternal circulation was raised approximately fourfold to 14506 ± 4124 pg/ml, p24 antigen passed to the fetal circulation in two of three placentas and in three of three placentas in the closed perfusion system. CONCLUSIONS: p24 antigen crossed the human placenta to the fetal circulation in what appears to be a concentration-dependent manner.

KW - ex vivo

KW - Human immunodeficiency virus-1 p24 antigen

KW - human placenta

KW - transfer

UR - http://www.scopus.com/inward/record.url?scp=0028922965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028922965&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(95)90568-5

DO - 10.1016/0002-9378(95)90568-5

M3 - Article

C2 - 7856681

AN - SCOPUS:0028922965

VL - 172

SP - 530

EP - 532

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 2 PART 1

ER -